Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review
- PMID: 18982835
Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review
Abstract
Background: Lithium is a drug used mainly for the treatment of Bipolar Disorder (BD). Case reports and several retrospective studies have demonstrated possible teratogenicity, but the data in the different studies was inconclusive.
Methods: We summarized all published studies in English, including case reports.
Results: We found 24 case reports, of which six infants had congenital anomalies, five having cardiac anomalies, one of them being Ebstein's anomaly. In the retrospective studies there were, in the Lithium Baby Registry, 225 registered cases with 25 anomalies, 18 of them being cardiac, of which six had Ebstein's anomaly. An additional retrospective study on 59 cases found seven anomalies, four of them being cardiac. On the other hand, none of the prospective studies (296 liveborn infants) demonstrated any increase in the rate of congenital anomalies, although two had Ebstein's anomaly. All case control studies regarding Ebstein's anomaly were negative, and among 222 infants with Ebstein's anomaly and 44 with tricuspid atresia none of the mothers had taken lithium during pregnancy.
Conclusions: Considering the serious limitations of the retrospective and case control studies that are also retrospective, lithium does not seem to be a significant teratogen, and hence should be given, if indicated, in pregnancy. It is, however, advisable to perform a fetal echocardiography to exclude the possibility of cardiac anomalies. Lamotrigine seems to be a possible alternative.
Comment in
-
Lithium and pregnancy.Isr J Psychiatry Relat Sci. 2008;45(4):300-1; author reply 301. Isr J Psychiatry Relat Sci. 2008. PMID: 19452657 No abstract available.
Similar articles
-
Lithium and Ebstein's anomaly.Cor Vasa. 1989;31(2):149-56. Cor Vasa. 1989. PMID: 2743779
-
[Ebstein's anomaly of the tricuspid valve following prenatal exposure to lithium].Ned Tijdschr Geneeskd. 1991 Jun 1;135(22):996-8. Ned Tijdschr Geneeskd. 1991. PMID: 2062397 Dutch.
-
[Is lithium a teratogen?].Cas Lek Cesk. 1996 Nov 20;135(22):726-8. Cas Lek Cesk. 1996. PMID: 8998825 Review. Czech.
-
A reevaluation of risk of in utero exposure to lithium.JAMA. 1994 Jan 12;271(2):146-50. JAMA. 1994. PMID: 8031346 Review.
-
Pulmonary atresia with intact ventricular septum: limitations of catheter-based intervention.Ann Thorac Surg. 2007 Aug;84(2):574-9; discussion 579-80. doi: 10.1016/j.athoracsur.2007.04.003. Ann Thorac Surg. 2007. PMID: 17643638
Cited by
-
Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes.Brain Sci. 2019 Sep 14;9(9):235. doi: 10.3390/brainsci9090235. Brain Sci. 2019. PMID: 31540060 Free PMC article. Review.
-
Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies.Lancet Psychiatry. 2018 Aug;5(8):644-652. doi: 10.1016/S2215-0366(18)30180-9. Epub 2018 Jun 18. Lancet Psychiatry. 2018. PMID: 29929874 Free PMC article.
-
Dose-Dependent Teratology in Humans: Clinical Implications for Prevention.Paediatr Drugs. 2018 Aug;20(4):331-335. doi: 10.1007/s40272-018-0294-0. Paediatr Drugs. 2018. PMID: 29725877 Review.
-
Using Lithium in Children and Adolescents with Bipolar Disorder: Efficacy, Tolerability, and Practical Considerations.Paediatr Drugs. 2018 Aug;20(4):303-314. doi: 10.1007/s40272-018-0289-x. Paediatr Drugs. 2018. PMID: 29651656 Review.
-
Pharmacological Management of Bipolar Disorder in Pregnancy.CNS Drugs. 2017 Sep;31(9):737-745. doi: 10.1007/s40263-017-0452-x. CNS Drugs. 2017. PMID: 28786084 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources